Live Breaking News & Updates on Isocabtagene Maraleuce
Stay updated with breaking news from Isocabtagene maraleuce. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The European Commission has approved lisocabtagene maraleucel for the treatment of adult patients with diffuse large B-cell lymphoma, high-grade B-cell lymphoma, primary mediastinal large B-cell lymphoma, and follicular lymphoma grade 3B who relapsed within 12 months from completion of, or are refractory to, first-line chemoimmunotherapy. ....